Block, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$6.56B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: XYZ stock price vs SNPS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SNPS's multiple
Needs SNPS P/E.
Implied fair value · at XYZ's multiple
Needs XYZ P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Block, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SYNOPSYS INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTUIT INC.
XYZ vs INTU
PayPal Holdings, Inc.
XYZ vs PYPL
Shift4 Payments, Inc.
XYZ vs FOUR
FISERV INC
XYZ vs FI
GLOBAL PAYMENTS INC
XYZ vs GPN
WEX Inc.
XYZ vs WEX
JUNIPER NETWORKS INC
XYZ vs JNPR
NVIDIA CORP
XYZ vs NVDA
ADVANCED MICRO DEVICES INC
XYZ vs AMD
INTEL CORP
XYZ vs INTC
Keysight Technologies, Inc.
XYZ vs KEYS
APPLIED MATERIALS INC /DE
XYZ vs AMAT
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe XYZ can reaccelerate growth and improve margins toward SNPS levels, then the current price offers relative upside because it already trades below the P/E-implied value and at a steep sales multiple discount to SNPS.
XYZ is priced at $82.09 versus an implied P/E value of $102.41, suggesting 24.7% upside on this framework. However, SNPS justifies a much richer revenue multiple, so the discount in XYZ is partly explained by weaker growth and profitability.
Supporting Metrics